|
Quotes & Info
|
| BJCT.OB > SEC Filings for BJCT.OB > Form 8-K on 7-May-2009 | All Recent SEC Filings |
7-May-2009
Results of Operations and Financial Condition, Financial Stateme
On May 6, 2009, Bioject Medical Technologies Inc. issued a press release announcing a net loss allocable to common shareholders of $0.2 million, or $0.01 per share, on revenues of $2.0 million for its first quarter ended March 31, 2009. A copy of the press release is attached as Exhibit 99.1.
(d) Exhibits
The following exhibit is furnished herewith and this list is intended to constitute the exhibit index:
99.1 Press release dated May 6, 2009 announcing Bioject Medical Technologies Inc.'s results for its first quarter ended March 31, 2009.
|
|